Transfusion therapy and acute lung injury

Expert Review of Respiratory Medicine

Volumn 4, Issue 3, 2010, Pages 387-393

  Sokolovic, Mladen ^a   Pastores, Stephen M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Critical illness; Management; Pathogenesis; Prevention; TRALI; Transfusion

Indexed keywords

FRESH FROZEN PLASMA; OXYGEN; THROMBOCYTE CONCENTRATE;

APHERESIS; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CRITICALLY ILL PATIENT; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL OXYGENATION; HUMAN; INCIDENCE; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMA TRANSFUSION; PRIMARY PREVENTION; REVIEW; RISK FACTOR; RISK REDUCTION; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT WITHDRAWAL;

EID: 77953233778     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.10.22     Document Type: Review

References (77)

1. Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am. Rev. Resp. Dis. 128, 185-189 (1983).
2. Covin RB, Ambruso DR, England KM et al. Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature. Transfusion Med. 14(5), 375-383 (2004).
3. O'Connor PC, Erskine JG, Pringle TH. Pulmonary oedema after transfusion with fresh frozen plasma. Br. Med. J. 282(6261), 379-380 (1981).
4. Ramanathan RK, Triulzi DJ, Logan TF. Transfusion-related acute lung injury following random donor platelet transfusion: a report of two cases. Vox Sang. 73(1), 43-45 (1997).
5. Rizk A, Gorson KC, Kenney L et al. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion 41(2), 264-268 (2001).
6. Reese EP Jr, McCullough JJ, Craddock PR. An adverse pulmonary reaction to cryoprecipitate in a hemophiliac. Transfusion 15(6), 583-588 (1975).
7. Urahama N, Tanosaki R, Masahiro K et al. TRALI after the infusion of marrow cells in a patient with acute lymphoblastic leukemia. Transfusion 43(11), 1553-1557 (2003).
8. Sachs UJ, Bux J. TRALI after the transfusion of cross-match-positive granulocytes. Transfusion 43(12), 1683-1686 (2003).
9. Gajic O, Rana R, Winters JL et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am. J. Respir. Crit. Care Med. 176(9), 886-891 (2007).
10. Khan H, Belsher J, Yilmaz M et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 131(5), 1308-1314 (2007).
11. Keller-Stanislawski B, Reil A, Gunay S et al. Frequency and severity of transfusion-related acute lung injury - German haemovigilance data (2006-2007). Vox Sang. 98(1), 70-77 (2009).
12. Chapman CE, Stainsby D, Jones H et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 49(3), 440-452 (2009).
13. Toy P, Popovsky MA, Abraham E et al. Transfusion-related acute lung injury: definition and review. Crit. Care Med. 33(4), 721-726 (2005).
14. Kleinman S, Caulfield T, Chan P et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44(12), 1774-1789 (2004).
15. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25(6), 573-577 (1985).
16. Benson AB, Moss M, Silliman CC. Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br. J. Haematol. 147(4), 431-443 (2009).
17. Gajic O, Rana R, Mendez JL et al. Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion 44(10), 1468-1474 (2004).
18. Gong MN, Thompson BT, Williams P et al. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit. Care Med. 33(6), 1191-1198 (2005).
19. Zilberberg MD, Carter C, Lefebvre P et al. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit. Care 11(3), R63 (2007).
20. Chaiwat O, Lang JD, Vavilala MS et al. Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma. Anesthesiology 110(2), 351-360 (2009).
21. Marik PE, Corwin HL. Acute lung injury following blood transfusion: expanding the definition. Crit. Care Med. 36(11), 3080-3084 (2008).
22. Li G, Kojicic M, Reriani MK et al. Long-term survival and quality of life after transfusion associated pulmonary edema in critically ill medical patients. Chest 137(4), 783-789 (2010).
23. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit. Care Med. 34(5 Suppl.), S124-S131 (2006).
24. Triulzi DJ. Transfusion-related acute lung injury: current concepts for the clinician. Anesth. Analg. 108(3), 770-776 (2009).
25. Seeger W, Schneider U, Kreusler B et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 76(7), 1438-1444 (1990).
26. Silliman CC, Bjornsen AJ, Wyman TH et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 43(5), 633-640 (2003).
27. Sachs UJ, Hattar K, Weissmann N et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 107(3), 1217-1219 (2006).
28. Looney MR, Su X, Van Ziffle JA et al. Neutrophils and their Fc g receptors are essential in a mouse model of transfusion-related acute lung injury. J. Clin. Invest. 116(6), 1615-1623 (2006).
29. Khan SY, Kelher MR, Heal JM et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 108(7), 2455-2462 (2006).
30. Looney MR, Nguyen JX, Hu Y et al. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J. Clin. Invest. 119(11), 3450-3461 (2009).
31. Brittingham TE. Immunologic studies on leukocytes. Vox Sang. 2(4), 242-248 (1957).
32. Cherry T, Steciuk M, Reddy VV et al. Transfusion-related acute lung injury: past, present, and future. Am. J. Clin. Pathol. 129(2), 287-297 (2008).
33. Silliman CC, Fung YL, Ball JB et al. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev. 23(6), 245-255 (2009).
34. Kopko PM, Marshall CS, MacKenzie MR et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 287(15), 1968-1971 (2002).
35. Muniz M, Sheldon S, Schuller RM et al. Patient-specific transfusion-related acute lung injury. Vox Sang. 94(1), 70-73 (2008).
36. Triulzi DJ, Kleinman S, Kakaiya RM et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 49(9), 1825-1835 (2009).
37. Sachs UJH, Link E, Hofmann C et al. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience. Transfusion Med. 18(6), 348-354 (2008).
38. Eder AF, Herron R, Strupp A et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47(4), 599-607 (2007).
39. Silliman CC, Clay KL, Thurman GW et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J. Lab. Clin. Med. 124(5), 684-694 (1994).
40. Silliman CC, Dickey WO, Paterson AJ et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 36(2), 133-139 (1996).
41. Rael LT, Bar-Or R, Ambruso DR et al. The effect of storage on the accumulation of oxidative biomarkers in donated packed red blood cells. J. Trauma 66(1), 76-81 (2009).
42. Gajic O, Gropper MA, Hubmayr RD. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit. Care Med. 34(5 Suppl.), S109-S113 (2006).
43. Burgher AH, Aslan D, Laudi N et al. Use of brain natriuretic peptide to evaluate transfusion-related acute lung injury. Transfusion 44(10), 1533-1534 (2004).
44. Tobian AA, Sokoll LJ, Tisch DJ et al. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 48(6), 1143-1150 (2008).
45. Zhou L, Giacherio D, Cooling L et al. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 45(7), 1056-1063 (2005).
46. Popovsky MA. Transfusion and the lung: circulatory overload and acute lung injury. Vox Sang. 87(Suppl. 2), 62-65 (2004).
47. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347(3), 161-167 (2002).
48. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 369(9572), 1553-1564 (2007).
49. Vlaar AP, Schultz MJ, Juffermans NP. Transfusion-related acute lung injury: a change of perspective. Neth. J. Med. 67(10), 320-326 (2009).
50. Lee AJ, Koyyalamudi PL, Martinez- Ruiz R. Severe transfusion-related acute lung injury managed with extracorporeal membrane oxygenation (ECMO) in an obstetric patient. J. Clin. Anesthesia 20(7), 549-552 (2008).
51. Kuroda H, Masuda Y, Imaizumi H et al. Successful extracorporeal membranous oxygenation for a patient with life-threatening transfusion-related acute lung injury. J. Anesthesia 23(3), 424-426 (2009).
52. Hebert PC, Wells G, Blajchman MA et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N. Engl. J. Med. 340(6), 409-417 (1999).
53. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit. Care Med. 36(9), 2667-2674 (2008).
54. Luk C, Eckert KM, Barr RM et al. Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines. CMAJ 166(12), 1539-1540 (2002).
55. Lauzier F, Cook D, Griffith L et al. Fresh frozen plasma transfusion in critically ill patients. Crit. Care Med. 35(7), 1655-1659 (2007).
56. Brunskill SJ, Hyde CJ, Stanworth SJ et al. Improving the evidence base for transfusion medicine: the work of the UK systematic review initiative. Transfusion Med. 19(2), 59-65 (2009).
57. Liumbruno G, Bennardello F, Lattanzio A et al. Recommendations for the transfusion of plasma and platelets. Blood Transfus. 7(2), 132-150 (2009).
58. Segal JB, Dzik WH; Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45(9), 1413-1425 (2005).
59. Wandt H, Frank M, Ehninger G et al. Safety and cost effectiveness of a 10 × 109/l trigger for prophylactic platelet transfusions compared with the traditional 20 × 109/l trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 91(10), 3601-3606 (1998).
60. Wandt H, Schaefer-Eckart K, Frank M et al. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 37(4), 387-392 (2006).
61. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 46(8), 1279-1285 (2006).
62. Eder AF, Benjamin RJ. TRALI risk reduction: donor and component management strategies. J. Clin. Apharesis 24(3), 122-129 (2009).
63. Triulzi DJ, Kleinman S, Kakaiya RM et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 49(9), 1825-1835 (2009).
64. Nguyen XD, Flesch B, Sachs UJ, Kroll H, Klüter H, Müller-Steinhardt M. Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test. Transfusion 49(12), 2700-2708 (2009).
65. Powers A, Stowell CP, Dzik WH et al. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 48(12), 2549-2558 (2008).
66. Kakaiya RM, Triulzi DJ, Wright DJ et al. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion DOI: 10.1111/j.1537-2995.2009.02556.x (2010) (Epub ahead of print).
67. Silliman CC, McLaughlin NJ. Transfusion-related acute lung injury. Blood Rev. 20(3), 139-159 (2006).
68. Mair DC, Hirschler N, Eastlund T. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI). Crit. Care Med. 34(5 Suppl.), S137-S143 (2006).
69. Flesland O. A comparison of complication rates based on published haemovigilance data. Intensive Care Med. 33(Suppl. 1), S17-S21 (2007).
70. Sachs UJ. The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion. Transfus. Apher. Sci. 37(3), 273-282 (2007).
71. Looney MR, Matthay MA. Animal models of transfusion-related acute lung injury. Crit. Care Med. 34(5 Suppl.), S132-S136 (2006).
72. Azoulay E, Attalah H, Harf A et al. Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data. Chest 120(5), 1695-1701 (2001).
73. Azoulay E, Attalah H, Yang K et al. Exacerbation with granulocyte colony-stimulating factor of prior acute lung injury during neutropenia recovery in rats. Crit. Care Med. 31(1), 157-165 (2003). (Pubitemid 36151166)
74. Karlin L, Darmon M, Thiery G et al. Respiratory status deterioration during G-CSF-induced neutropenia recovery. Bone Marrow Transplant. 36(3), 245-250 (2005).
75. Hishizawa M, Mitsuhashi R, Ohno T. Transfusion-related acute lung injury (TRALI) induced by donor-derived anti-HLA antibodies in aplastic anemia: possible priming effect of granulocyte-colony stimulating factor (G-CSF) on the recipient neutrophils. Int. Med. 48(22), 1979-1983 (2009).
76. Napolitano LM, Kurek S, Luchette FA et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit. Care Med. 37(12), 3124-3157 (2009).
77. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev. 23(6), 231-240 (2009).